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The number of deaths in England and Wales associ-
ated with gastrointestinal pathogens, norovirus in particu-
lar, in persons >65 years was estimated for 2001–2006. 
Regression analysis was used to model monthly counts of 
gastrointestinal pathogens in fecal samples from infected 
patients against monthly counts of deaths from infectious 
and noninfectious intestinal diseases. Data came from the 
Ofﬁ  ce of National Statistics (death registrations from local 
registrars) and from the Health Protection Agency (laborato-
ry results).  Model results suggest that 20% (13.3%–26.8%) 
of deaths in persons >65 years of age caused by infectious 
intestinal disease other than Clostridium difﬁ  cile were as-
sociated with norovirus infection in this period and that 13% 
(7.5%–18.5%) of deaths caused by noninfectious intestinal 
disease were associated with norovirus. An estimated 80 
deaths each year in this age group may be associated with 
norovirus infection.
E
stimating the number of deaths associated with infec-
tion is challenging. Deaths resulting from infectious 
diseases tend to be underreported on death certiﬁ  cates (1). 
Similarly, laboratory reports record the pathogens detected 
but rarely record long-term outcomes, such as death or 
other sequelae. Routine hospital admissions and discharge 
data only record deaths that occur in hospital, and coding 
may not always be complete or accurate, especially if diag-
nostic results are not available (2,3).
Norovirus is the most common cause of acute gastro-
intestinal infections and causes most reported outbreaks 
of gastrointestinal disease in England and Wales (4). Out-
breaks occur more often during the winter months of Oc-
tober to March (5), but occasionally unexpectedly high 
activity can occur during the summer months (6). To date, 
no published data estimate the number of deaths from noro-
virus infections in the United Kingdom. We estimated the 
number of deaths associated with gastrointestinal pathogens 
by using previously reported methods (1,2,7–9) and, in par-
ticular, we estimated the seasonal contribution of norovirus 
to death in the elderly (>65 years of age). We also tested 
the hypothesis that the 2002–03 norovirus season, when a 
novel strain emerged (10), was associated with more patho-
genicity than were other norovirus seasons.
Methods
Data Sources
Laboratory Reports
The Health Protection Agency collects data from labo-
ratories around England and Wales on pathogens identiﬁ  ed 
in fecal samples from infected patients with gastrointestinal 
symptoms (11). Samples come from persons in the commu-
nity (taken by general practitioners), from persons involved 
in outbreaks (taken by Environmental Health Ofﬁ  cers), and 
from hospitalized patients. Monthly counts (based on the 
date the specimen was taken) of positive specimens for 
January 2001–December 2006 were extracted for those 
>65 years of age. The organisms responsible for gastroin-
testinal diseases extracted for the analysis were Salmonella 
spp., Shigella spp., Campylobacter spp., Escherichia coli 
(not Shiga-toxin producing), enteric adenovirus, rotavirus, 
astrovirus, norovirus, Cryptosporidium spp., and Giardia 
spp. All other intestinal parasitic diseases were grouped 
together as other parasites. All bacterial pathogens were 
grouped by genera; e.g., all Campylobacter spp. were 
grouped together.
Mortality Statistics
The Ofﬁ  ce of National Statistics (ONS) compiles mor-
tality statistics based on death registrations from local regis-
Deaths from Norovirus among the 
Elderly, England and Wales
John P. Harris, W. John Edmunds, Richard Pebody, David W. Brown, and Ben A. Lopman
RESEARCH
1546  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 10, October 2008
Author afﬁ  liation: Health Protection Agency, London, UK 
DOI:  10.3201/eid1410.080188Deaths from Norovirus among the Elderly
trars in England and Wales. Cause-of-death information on 
death certiﬁ  cates is coded by ONS according to the Interna-
tional Classiﬁ  cation of Diseases, 10th revision. Annually, 
ONS provides HPA with a ﬁ  le of all deaths that mention an 
infectious disease code. Deaths with a code for an infec-
tious intestinal disease (ID), either as the underlying cause 
of death or a contributing cause of death, were extracted 
for 2001–2006 for persons >65 years of age (Table 1). We 
repeated the exercise for deaths that were considered to be 
caused by noninfectious ID. Deaths with any mention of 
Clostridium difﬁ  cile were excluded from the analysis.
Statistical Analyses
Because most gastrointestinal pathogens are highly 
seasonal, we estimated the number of gastrointestinal-
related deaths by regressing monthly counts of laboratory 
reports on monthly counts of deaths. As we could not as-
sume monthly counts of deaths to be normally distributed, 
simple linear regression models were inappropriate. We 
modeled monthly counts of deaths as a Poisson distribu-
tion, which has properties appropriate for analysis of count 
data. We used generalized linear regression models, which 
are used to extend simple linear regression to incorporate 
other distributions, to model monthly deaths as a Poisson-
distributed outcome of laboratory reports of gastrointesti-
nal pathogens. 
Poisson regression also assumes that the data are not 
overdispersed (i.e., the variance is equal to the mean). 
Negative binomial models relax this assumption; we also 
considered negative binomial models, although they gave 
no qualitative differences in the results. To estimate the 
number of deaths that may be attributed to each pathogen, 
all models were ﬁ  tted by using STATA 10.0 (12).
Our approach assumed a ﬁ  xed proportion of labora-
tory reports for each organism to deaths over the period 
examined. The initial model included all laboratory reports 
for the extracted organisms as explanatory variables (Table 
2). A constant term was included in all models to account 
for deaths not explained by the seasonal variation in labora-
tory reports. Because the number of deaths reported in each 
year (from both infectious and noninfectious ID) exhibited 
an upward trend during the study period, an independent 
term, consisting of year and month, was ﬁ  tted to the model 
to account for this trend. In the initial full model, monthly 
deaths were modeled as a function of laboratory reports for 
each gastrointestinal pathogen (11 terms), the linear time 
variable, and a constant term (Table 2). Pathogens were 
removed if the coefﬁ  cient was negative (because that was 
considered not biologically plausible) or if the variable was 
not signiﬁ  cant in the model (p>0.05) to give the most parsi-
monious model. Model coefﬁ  cients are on the natural scale 
(i.e., they represent directly how many deaths are associ-
ated with each laboratory report). The number of deaths in 
each month was estimated by multiplying the coefﬁ  cient 
from the regression model for the pathogen by the number 
of monthly laboratory reports for that pathogen. Norovirus 
activity is highly seasonal; therefore, the number of deaths 
was also calculated with the year beginning in July and 
ending in June.
We carried out 2 additional analyses to test whether the 
2002–03 season, when a novel norovirus strain emerged, 
was associated with increased pathogenicity. First, we 
tested for an interaction between the 2002–03 season and 
laboratory reports of norovirus. We looked for a signiﬁ  cant 
difference in the relationship between laboratory reports 
of norovirus and deaths in 2002–03 season compared with 
other seasons (i.e., effect modiﬁ  cation). A higher coefﬁ  -
cient would indicate higher pathogenicity in this epidemic 
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Table 1. International Classification of Diseases, 10th Revision, 
codes used for defining deaths from infectious and noninfectious 
causes, England and Wales, 2001–2006 
Code Diagnosis
A00 Cholera
A01 Typhoid and paratyphoid fevers 
A02 Other Salmonella infections 
A03 Shigellosis
A04 Other bacterial intestinal infections (excludes A047, 
Clostridium difficile)
A05 Other bacterial foodborne intoxications 
A06 Amebiasis
A07 Other protozoal intestinal diseases 
A08 Rotaviral enteritis 
A09 Diarrhea and gastroenteritis of presumed infectious 
origin 
A212* Pulmonary tularemia 
A213* Gastrointestinal tularemia 
B462* Gastrointestinal mucormycosis 
K22* Other diseases of esophagus 
K229 Disease of esophagus, unspecified 
K29* Gastritis and duodenitis 
K299 Gastroduodenitis, unspecified 
K31* Other diseases of stomach and duodenum 
K319 Disease of stomach and duodenum, unspecified 
K521 Toxic gastroenteritis and colitis 
K528 Other specified noninfective gastroenteritis and colitis 
K529 Noninfective gastroenteritis and colitis, unspecified 
K92* Other diseases of digestive system 
K929 Disease of digestive system, unspecified 
T47* Poison agents primarily affecting the gastrointestinal 
system 
T478* Poisoning by other agents primarily affecting the 
gastrointestinal system 
T479* Poisoning by agent primarily affecting the 
gastrointestinal system unspecified 
Y53*  Agents primarily affecting the gastrointestinal system 
Y538*  Other agents primarily affecting the gastrointestinal 
system 
Y539*  Agent primarily affecting the gastrointestinal system, 
unspecified
*Although these codes were used in the search, none yielded any results 
for use in our dataset. RESEARCH
season. Secondly, we calculated a ratio of deaths to labo-
ratory reports by dividing the number of deaths with any 
direct mention of viral gastroenteritis on the death certiﬁ  -
cate by the number of laboratory reports of norovirus in the 
corresponding year.
Results
During 2001–2006, a total of 1,136 deaths were re-
corded with any code for infectious ID and 1,736 for 
noninfectious ID (Figure 1). Infectious and noninfectious 
ID–associated deaths were correlated (R2 = 0.33, p = 0.10, 
Figure 1) and exhibited a wintertime seasonal pattern. Over 
the same period (2001–2006) in England and Wales, a total 
of 65,932 laboratory reports of the pathogens of interest 
were submitted for those >65 years of age. Summertime 
seasonality of the major bacterial pathogens and the win-
tertime seasonality of viral pathogens for this age group are 
illustrated in Figure 2, panels A–C.
Table 2 shows the comparisons of the best ﬁ  tting mod-
els for infectious and noninfectious ID–associated deaths. 
Norovirus was the only pathogen signiﬁ  cantly associated 
with monthly counts of infectious ID deaths (p<0.001). 
All other pathogens were removed from the model. In the 
noninfectious ID deaths model, astrovirus was also signiﬁ  -
cant (p = 0.02). Because astrovirus infection is rare in the 
elderly (4) and shares a similar seasonality with norovirus, 
we decided to leave it out of the ﬁ  nal model. A linear term, 
accounting for the general increasing trend in the num-
ber of deaths reported, signiﬁ  cantly improved the model 
(p<0.001) and was included in the ﬁ  nal estimation. Noro-
virus remained the only signiﬁ  cant pathogen in the model. 
Therefore, in the ﬁ  nal models the expected number of no-
rovirus deaths was modeled as a Poisson distribution of 
laboratory reports of norovirus and a linear time variable. 
Some slight overdispersion was evident in the infectious 
ID deaths model, but ﬁ  tting an alternative model to account 
for the overdispersion, negative binomial models, did not 
substantially alter the results, which suggests that Poisson 
regression is not inappropriate in this case.
The model estimates that during 2001–2006, a total of 
228 deaths from infectious ID were associated with noro-
virus infection, which represents 20% (13.3%–26.8%) of 
deaths from infectious ID in those >65 years of age; 225 
(13% [7.5%–18.5%]) of deaths from noninfectious ID were 
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Table 2. Regression model results for deaths from infectious and noninfectious gastrointestinal disease in persons >65 years of age, 
England and Wales, 2001–2006 
Initial full model  Final model 
Pathogen Coefficient* p value†  Coefficient* p value† 
Infectious intestinal disease models 
 Norovirus  0.0134 0.003 0.0174 <0.001
 Astrovirus  –0.059 0.415 –
Shigella spp.  0.103 0.528 –
 Rotavirus  –0.055 0.003 –
Campylobacter spp.  –0.017 0.001 –
Escherichia coli  0.067 0.612 –
Cryptosporidium spp.  –0.151 0.122 –
Giardia spp.  –0.165 0.209 –
 Other  parasites  –0.012 0.890 –
Salmonella spp.  –0.011 0.478 –
 Adenovirus  –0.341 0.266 –
 Time  trend  1.437 <0.001 1.611 <0.001
 Constant  23.11 <0.001 6.239 <0.001
Noninfectious intestinal disease models 
 Norovirus  0.0134 0.011 0.0173 <0.001
 Astrovirus  0.115 0.198 –
Shigella spp. 0.240 0.221 –
 Rotavirus  –0.066 0.004 –
Campylobacter spp.  0.001 0.903 –
E. coli  –0.088 0.566 –
Cryptosporidium spp.  –0.125 0.315 –
Giardia spp.  –0.030 0.860 –
 Other  parasites  –0.081 0.439 –
Salmonella spp.  –0.039 0.050 –
 Adenovirus  0.0147 0.967 –
 Time  trend  2.008 <0.001 2.488 <0.001
 Constant  20.240 <0.001 11.135 <0.001
*The coefficient represents the number of deaths associated with each laboratory report for each pathogen. The constant (intercept term) indicates 
monthly deaths associated with other causes. 
†Wald test. Deaths from Norovirus among the Elderly
associated with norovirus. Thus, the annual average num-
ber of deaths (January to December) from both infectious 
ID and noninfectious ID was 38; however, when looking at 
the period from July to June in each year, to account for the 
norovirus season, the average was ≈40 each season (Table 
3). Figure 3, panels A, B, illustrates that models ﬁ  t better to 
the deaths from infectious ID but still show some associa-
tion with the deaths from noninfectious ID.
In years with high seasonal activity, numbers of no-
rovirus-associated deaths were higher. The overall death/
laboratory report ratio for 2001–2006 was 55/1,000 (95% 
conﬁ  dence interval [CI] 51–60). The ratio did not increase 
in the years with greater numbers of deaths (Figure 4), and 
we found no evidence that the ratio was signiﬁ  cantly higher 
during any of the study years. The 2002–03 season had the 
lowest death/laboratory report ratio. Including an interac-
tion term in the infectious ID model between the epidemic 
2002–03 season and laboratory reports of norovirus resulted 
in a negative-coefﬁ  cient interaction term (likelihood ratio 
test p value = 0.002). This ﬁ  nding suggests a lower death/
laboratory report ratio in the 2002–03 season, contrary to 
the hypothesis we were testing. The relative risk for death 
in the 2002–03 season compared with all other seasons was 
0.81 (95% CI 0.69–0.96, p = 0.016).
In an analysis of recorded causes for all infectious ID 
deaths, viral gastroenteritis was speciﬁ  cally listed as an un-
derlying cause for 13.4% of deaths (152/1,136). Table 4 
shows the distribution of recorded underlying causes when 
viral gastroenteritis was mentioned as a contributory cause 
in 20% (227/1,136) of infectious ID deaths. For noninfec-
tious ID deaths, diseases of the digestive system accounted 
for 52% (898/1,736) of the recorded underlying causes. Of 
these, 92% (829/898) were caused by unspeciﬁ  ed nonin-
fectious gastroenteritis and colitis.
Discussion
Over the 6-year period of our study, the total number 
of deaths in persons >65 years of age that may be attribut-
able to norovirus was 453 (228 from infectious ID and 225 
from noninfectious ID). On average, this equates to ≈80 
deaths each year attributable to norovirus infection. Noro-
virus was the only gastrointestinal pathogen that was con-
sistently signiﬁ  cant in the 2 regression models.
Of the recorded deaths from infectious ID, 13% had vi-
ral gastroenteritis listed as the underlying cause. For deaths 
from noninfectious ID, 48% had an underlying cause of un-
speciﬁ  ed noninfectious gastroenteritis and colitis. Because 
these are unspeciﬁ  ed causes, and given their similar sea-
sonality with infectious ID, many of these are likely to be 
infectious causes that were misclassiﬁ  ed.
In years with higher norovirus activity, more deaths 
were associated with norovirus infection. However, we 
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Figure 1. Correlation of monthly death reports of infectious and 
noninfectious intestinal disease, England and Wales, 2001–2006.
Figure 2. Seasonality of positive laboratory reports of viral (A), bacterial (B), and parasitic (C) pathogens, persons >65 years of age, 
England and Wales, 2001–2006.RESEARCH
found no evidence of increased pathogenicity in years with 
higher recorded norovirus activity. The season when a new 
variant of the genotype II.4 virus emerged (2002–03) did 
not coincide with an increase in death/laboratory-report 
ratio. Indeed, the opposite was observed; fewer deaths as 
a proportion of positive laboratory reports were observed, 
the interaction term showed a negative coefﬁ  cient for that 
season, and the relative risk for death during that season 
was lower than during other seasons.
One of the assumptions in our regression model was 
that laboratory reporting was consistent over the time of the 
study. Laboratory reporting processes did not change dur-
ing the years of the study and are unlikely to have caused 
bias in this study. Testing and reporting behavior, how-
ever, may have changed over time. The number of speci-
mens identiﬁ  ed by PCR and ELISA increased from ≈70% 
to ≈90% in the study period. Thus, the decreased ratio of 
deaths/laboratory reports may have resulted from increased 
testing during the 2002–03 season rather than from the vi-
rus being less pathogenic during that year.
The modeling approach may underestimate the contri-
bution of norovirus and other pathogens because the meth-
od estimates how much of the seasonal variation in death is 
associated with the seasonal variation in laboratory reports. 
Less-seasonal pathogens are less likely to show an associa-
tion, and nonseasonal components (i.e., background levels) 
will not be attributed to a pathogen. Indeed, a substantial 
constant term in our models represented these unattributed 
deaths. The model for deaths from noninfectious ID did not 
appear to be as good a ﬁ  t as the model for deaths from in-
fectious ID. There was, in our opinion, enough evidence of 
a correlation between infectious and noninfectious ID to 
make a case for including this model.
This method has been used in the past for other patho-
gens (rotavirus, respiratory syncytial virus, pneumococcus, 
inﬂ  uenza virus) and unexplained deaths; when we used it in 
this study, we found an association between norovirus and 
death. Until our study, most reports of norovirus-associated 
deaths have been anecdotal (13). Although deaths associat-
ed with norovirus infection have been documented (14,15), 
these are usually singular reports of patients having died 
subsequent to infection with norovirus, rather than in-depth 
analysis of time trends of death.
In this study we attempted to go further and estimate 
the extent of death from norovirus. Norovirus is usually 
considered a mild, self-limiting disease, and most of those 
infected with the disease make a full recovery with no long-
lasting effects. However, this study shows that part of the 
population, those >65 years of age, have a small risk of dy-
ing as a result of contracting norovirus. Rates of infection 
are higher within healthcare settings than in the commu-
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Table 3. Estimated number of deaths in each season (July to June) from the regression models, England and Wales, 2001–2006 
Predicted annual deaths, no. (95% confidence interval)
Year 
Infectious intestinal disease 
only
Noninfectious intestinal disease 
only
Infectious and noninfectious intestinal 
disease
2001–02 22.2 (14.7–29.7) 21.9 (12.7–31.2) 44.3 (32.4–56.2)
2002–03 59.5 (39.4–79.5 ) 58.8 (34.0–83.7) 118.9 (86.9–150.8)
2003–04 18.4(12.2–24.6) 18.2 (10.5–25.9) 36.8 (26.9–46.7)
2004–05 51.4(34.1–68.8) 50.9 (29.4–72.4) 102.8 (75.2–130.5)
2005–06 51.8(34.3–69.3) 51.3 (29.6–72.9) 103.6 (75.7–131.4)
Total 203.3 (134.6–272.0) 201.2 (116.1–286.2) 406.5 (297.2–515.7)
Annual mean 40.7 40.2 81.3
Figure 3. Observed and expected monthly deaths in persons >65 
years of age from infectious intestinal diseases (A) and noninfectious 
intestinal diseases (B), derived from the most parsimonious models. 
England and Wales, 2001–2006.Deaths from Norovirus among the Elderly
nity (4,15,16). Previous studies have shown that hospital 
patients who are involved in outbreaks of norovirus are ill 
longer than those who become infected in other settings 
(15). In England the proportion of the population >65 years 
of age is increasing. In years to come, this will be a sub-
stantial proportion of persons at risk, and deaths associated 
with this disease may well increase.
Noroviruses are known to evolve quickly. Emergence 
of new variants of the most commonly circulating strain 
can cause epidemic years in which more outbreaks occur 
and many more persons are infected. New variants are also 
associated with out-of-season activity, i.e., more outbreaks 
and infections than usual occurring in summer. When this 
happens, most of the population may be susceptible to in-
fection. Our study suggests that when such epidemics oc-
cur, the number of norovirus-associated deaths increases 
as a result of the large number of persons infected rather 
than from increased virulence. Nevertheless, a measurable 
amount of death is associated with norovirus infection ev-
ery year.
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Table 4. Recorded underlying causes of death in persons in 
whom viral infectious intestinal disease was a contributory factor 
Underlying cause of death %
Infectious intestinal disease (viral) 40.2
Circulatory system disorder 32.8
Respiratory system disorder 9.0
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Digestive system disorder 2.5
Nervous system disorder 2.5
Endocrine, nutritional, and  metabolic disorders 2.5
Infectious intestinal disease (bacterial) 1.6
Mental/behavioral disorder 1.6
Musculoskeletal and connective tissue disorder 1.6
Genitourinary system disorder 0.8
Figure 4. Ratio of viral gastroenteritis–associated death reports to 
norovirus laboratory reports, 5 norovirus seasons (2001–2006), 
England and Wales.
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